We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$76.1B
AUM Growth
+$4.53B
(+6.3%)
Cap. Flow
-$133M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
798
New
67
Increased
286
Reduced
299
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$550M |
| 2 |
Goldman Sachs
GS
|
+$448M |
| 3 |
ConocoPhillips
COP
|
+$390M |
| 4 |
BorgWarner
BWA
|
+$373M |
| 5 |
Marathon Petroleum
MPC
|
+$365M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$545M |
| 2 |
Occidental Petroleum
OXY
|
+$491M |
| 3 |
Verizon
VZ
|
+$433M |
| 4 |
RTN
Raytheon Company
RTN
|
+$266M |
| 5 |
Aon
AON
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.05% |
| 2 | Healthcare | 13.47% |
| 3 | Technology | 12.73% |
| 4 | Energy | 10.48% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
PayPal
PYPL
$49.5B
| $69.5M | 0.09% |
1,759,821
+110,872
| +7% | +$4.46M |
|
202
Northrop Grumman
NOC
$77B
| $68.4M | 0.09% |
293,921
+44,706
| +18% | +$10.4M |
|
|
WRD
203
DELISTED
WildHorse Resource Development
WRD
| $68.1M | 0.09% |
+4,663,707
| New | +$68M |
|
204
Avnet
AVT
$7.33B
| $67.1M | 0.09% |
1,408,457
-12,715
| -0.9% | -$567K |
|
205
CDW
CDW
$17.1B
| $66.1M | 0.09% |
1,269,065
-432,427
| -25% | -$21.1M |
|
206
American Eagle Outfitters
AEO
$2.85B
| $65.9M | 0.09% |
4,342,459
+2,108,517
| +94% | +$36.1M |
|
207
Western Digital
WDC
$179B
| $64.7M | 0.09% |
1,259,604
-710,826
| -36% | -$32.8M |
|
208
Electronic Arts
EA
$52.4B
| $63.4M | 0.08% |
805,088
+1,177
| +0.1% | +$94.7K |
|
209
Lear
LEA
$7.19B
| $62.6M | 0.08% |
472,905
-401,909
| -46% | -$50.6M |
|
210
Constellation Brands
STZ
$22.2B
| $61.6M | 0.08% |
401,568
-96,100
| -19% | -$15.3M |
|
211
Radian Group
RDN
$5.14B
| $60.2M | 0.08% |
3,348,992
+11,697
| +0.4% | +$176K |
|
212
Teva Pharmaceuticals
TEVA
$35.9B
| $58.2M | 0.08% |
1,604,180
-363,872
| -18% | -$14.5M |
|
|
TLRD
213
DELISTED
Tailored Brands, Inc.
TLRD
| $57.8M | 0.08% |
2,262,945
-10,698
| -0.5% | -$207K |
|
|
SF
214
Stifel
SF
$12.3B
| $57.5M | 0.08% |
2,588,173
-7,672
| -0.3% | -$154K |
|
|
RAI
215
DELISTED
Reynolds American Inc
RAI
| $57M | 0.08% |
1,017,391
-506,601
| -33% | -$26.9M |
|
216
ICICI Bank
IBN
$106B
| $56.1M | 0.07% |
8,241,019
+3,931,123
| +91% | +$28M |
|
217
Essent Group
ESNT
$6.06B
| $56M | 0.07% |
1,729,134
+8,413
| +0.5% | +$248K |
|
|
BWP
218
DELISTED
Boardwalk Pipeline Partners
BWP
| $54.8M | 0.07% |
3,157,981
+27,806
| +0.9% | +$475K |
|
219
American Express
AXP
$223B
| $53.3M | 0.07% |
719,858
-4,029
| -0.6% | -$279K |
|
220
Moody's
MCO
$82.4B
| $52.9M | 0.07% |
561,611
-74,909
| -12% | -$7.56M |
|
221
Walker & Dunlop
WD
$1.65B
| $52.7M | 0.07% |
1,689,219
-6,584
| -0.4% | -$185K |
|
222
Nelnet
NNI
$4.79B
| $52.6M | 0.07% |
1,036,585
-9,724
| -0.9% | -$448K |
|
|
TWO
223
Two Harbors Investment
TWO
$1.27B
| $51.9M | 0.07% |
743,587
+98,906
| +15% | +$6.73M |
|
224
EnerSys
ENS
$6.95B
| $51.4M | 0.07% |
658,720
+2,301
| +0.4% | +$169K |
|
225
HCA Healthcare
HCA
$84.8B
| $51.2M | 0.07% |
691,246
+451,067
| +188% | +$33.8M |
|
Similar funds
Boston Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Boston Partners held 798 positions worth $76.1B, up 6.3% from $71.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q4 2016 filing shows 67 new, 286 increased, 299 reduced and 53 closed positions. Its largest new stake was BorgWarner: 11,568,722 shares worth $402M. The largest sale was McKesson, an estimated $545M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q4 2016 buy was BorgWarner: 11,568,722 shares worth $402M.
- Boston Partners added most to Pfizer in Q4 2016, an estimated $550M increase.
- Boston Partners's biggest Q4 2016 reduction was McKesson, cutting an estimated $545M.
- Boston Partners fully exited Valspar in Q4 2016, selling an estimated $177M.
- Boston Partners's ten largest holdings make up 17% of its $76.1B portfolio in Q4 2016.
- Boston Partners opened 67 new positions and closed 53 in Q4 2016.
- Boston Partners's portfolio value rose 6.3% quarter-over-quarter to $76.1B.
Based on Boston Partners's 13F filing for Q4 2016, filed 6 Feb 2017.